HomeProcedural SolutionsOsteoSurge® 100
Products

OsteoSurge® 100

Our OsteoSurge® 100 grafts combine demineralized bone matrix with patented Accell® Bone Matrix in a bio-resorbable, reverse-phase medium carrier. Provided in a syringe, the putty is moldable and resists irrigation. The putty may be implanted directly from the syringe.
seaspine
Key Features & Technologies

Focused on the details.

  1. Key Features
  2. Technologies
  1. Accell Technology - The patented Accell process yields Accell bone matrix (ABM). ABM is an open-structured, dispersed form of DBM
    • Superior Handling - The unique, poloxamer, reverse phase medium carrier, which becomes more viscous at body temperature, provides exceptional handling and containment characteristics. The graft is moldable, packable, mixable and resists irrigation
      • Verified Osteoinductive Potential - Every lot of DBM is tested in a validated, in vitro assay to verify osteoinductive potential
        • Expert Processing - Ground cortical bone and cancellous bone obtained from AATB-accredited tissue banks is processed into DBM in our state-of-the-art facility. The demineralization process is tightly controlled to consistently produce demineralized bone
          • Electron Beam Sterilization - The processing of DBM and ABM is completed under aseptic conditions in our state-of-the-art facility. As the last step in manufacturing, the graft is sterilized via electron beam irradiation
            eIFU

            OsteoSurge® 100 eIFUs